Transforming Rare Disease Care in India with Cell and Gene Therapies

Entertainment National Sports Markets Business & Economy Lifestyle World Astrology & Religion Technology Education & Jobs Auto Politics Viral Opinions

Loading more articles...

Cell and Gene Therapies Revolutionize Rare Disease Care in India

Opening New Medical Frontiers | These discoveries have opened new medical frontiers for treating autoimmune diseases, improving cancer therapies, and preventing complications after transplantations. Regulatory T cells are often found in cancerous tumors, where they may shield the tumor from immune attack. Researchers are exploring ways to overcome this protection. Understanding FOXP3 and regulatory T cells now allows scientists to design therapies that reprogram the immune system to fight cancer or reduce autoimmunity, offering hope for more precise and effective medical interventions. Scientists are also working on genetically modified versions of T cells to promote organ transplant tolerance—the body’s ability to accept foreign tissue from a donor. (Image: Canva)

C

CNBC TV18•19-02-2026, 13:55

Cell and Gene Therapies Revolutionize Rare Disease Care in India

•Cell and gene therapies (CGT) offer significant promise for rare diseases, blood cancers, and autoimmune disorders in India.
•India's CGT ecosystem is rapidly evolving with government support from DBT and BIRAC, boosting startups and bioeconomy.
•The Indian CGT market, valued at $710.91 million in 2024, is projected to reach $2.5 billion by 2033, attracting global players.
•Increased investment in translational research, advanced manufacturing, and GMP-compliant infrastructure is transforming care.
•Workforce readiness and regulatory alignment are crucial for building sustainable CGT capacity and improving accessibility.

Read Full Article on Cnbc in English

✦

More like this

✦

More like this

Cell & Gene Therapy: A Cancer Cure Breakthrough Explained by Doctors

Cell & Gene Therapy: A Cancer Cure Breakthrough Explained by Doctors

ग्‍लोबल न्यूट्रास्यूटिकल बाजार 2030 तक 919 अरब डॉलर तक पहुंचेगा.

India Boosts Health Industry with Rs 10,000 Crore Fund, Nutraceuticals Poised for Growth

एम्स की एक स्टडी में जीएसटी रिफॉर्म से कैंसर के इलाज में फायदा होने की बात सामने आई है.

GST Reforms Slash Cancer Treatment Costs, AIIMS Researchers Applaud Policy Shift

Representational image (Image: News18)

Genomics: Key to Viksit Bharat 2047's Health and Economic Growth

: Automotive Component Manufacturers Association of India (ACMA) press conference, (from left )Vinnie Mehta, director general, ACMA; Vikrampati Singhania, President, ACMA; Vikram Janakiraman, MD and senior partner, BCG; Saurabh Chhajer, MD and partner, BCG.
Photo by Madhu Kapparath

Indian Auto Parts Makers Embrace Automation for Global Growth, Export Target $100 Billion

Among key recommendations is extending priority or expedited pathways for novel biologics, rare disease, and breakthrough therapies. (Image for representation: AFP)

India Overhauls Drug Regulation: New Guidelines for mRNA, Gene Therapy on Anvil